by Admin | Jun 6, 2019 | News & Opinions
ISSCR News – 5 June, 2019 – The International Society for Stem Cell Research (ISSCR), the largest professional organization of stem cell researchers from around the world, opposes the new U.S. Health and Human Services policy to eliminate federal funding...
![Federal court issues decision holding that US Stem Cell clinics and owner adulterated and misbranded stem cell products in violation of the law]()
by Admin | Jun 4, 2019 | News & Opinions
FDA Press Release: June 04, 2019 – U.S. District Judge Ursula Ungaro of the Southern District of Florida granted the government’s motion for summary judgment against US Stem Cell Clinic LLC, of Weston, Florida, and US Stem Cell Inc., of Sunrise, Florida, and...
![Federal court issues decision holding that US Stem Cell clinics and owner adulterated and misbranded stem cell products in violation of the law]()
by Admin | May 31, 2019 | News & Opinions
DURHAM, N.C. (PRWEB)May 30, 2019 – A study released today in STEM CELLS Translational Medicine is the first to demonstrate an efficient delivery system for the sustained release of human placental stem cell (HPSC)-derived conditioned medium (CM) to treat acute...
by Admin | May 11, 2019 | News & Opinions
WINSTON-SALEM, NC – The sixth annual Regenerative Medicine Essentials Course will be held June 10 – 14 in downtown Winston-Salem. The course is made possible through the collaborative partnership between the Regenerative Medicine Foundation (RMF) and the Wake...
![Federal court issues decision holding that US Stem Cell clinics and owner adulterated and misbranded stem cell products in violation of the law]()
by Admin | May 9, 2019 | News & Opinions
One of the biggest investment opportunities over the next decade will be in companies working to delay human death, a market expected to be worth at least $600 billion by 2025, according to Bank of America analysts. The analysts say companies such as Illumina and...
![Federal court issues decision holding that US Stem Cell clinics and owner adulterated and misbranded stem cell products in violation of the law]()
by Admin | May 8, 2019 | News & Opinions
Under a draft proposal, patients would be able to buy some therapies without regulatory approval. By: David Cyranoski Select elite hospitals in China could soon be able to sell experimental therapies that engineer a patient’s own cells to treat diseases such as cancer...
